ATE526917T1 - Pharmazeutische zusammensetzung - Google Patents

Pharmazeutische zusammensetzung

Info

Publication number
ATE526917T1
ATE526917T1 AT01916128T AT01916128T ATE526917T1 AT E526917 T1 ATE526917 T1 AT E526917T1 AT 01916128 T AT01916128 T AT 01916128T AT 01916128 T AT01916128 T AT 01916128T AT E526917 T1 ATE526917 T1 AT E526917T1
Authority
AT
Austria
Prior art keywords
membrane
nail
forming
solvent
solution
Prior art date
Application number
AT01916128T
Other languages
German (de)
English (en)
Inventor
Robert Gyurik
Original Assignee
Cpex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cpex Pharmaceuticals Inc filed Critical Cpex Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE526917T1 publication Critical patent/ATE526917T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01916128T 2000-02-16 2001-02-16 Pharmazeutische zusammensetzung ATE526917T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18292400P 2000-02-16 2000-02-16
PCT/US2001/005302 WO2001060325A1 (en) 2000-02-16 2001-02-16 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE526917T1 true ATE526917T1 (de) 2011-10-15

Family

ID=22670647

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01916128T ATE526917T1 (de) 2000-02-16 2001-02-16 Pharmazeutische zusammensetzung

Country Status (17)

Country Link
EP (1) EP1257248B1 (enExample)
JP (1) JP2005503318A (enExample)
KR (2) KR20030016227A (enExample)
CN (1) CN1422142A (enExample)
AT (1) ATE526917T1 (enExample)
AU (2) AU4318901A (enExample)
BR (1) BR0108438A (enExample)
CA (1) CA2400178A1 (enExample)
HU (1) HUP0204555A3 (enExample)
MA (1) MA26883A1 (enExample)
MX (1) MXPA02008072A (enExample)
NO (1) NO20023866L (enExample)
NZ (1) NZ520749A (enExample)
PL (1) PL357111A1 (enExample)
TW (1) TWI232756B (enExample)
WO (1) WO2001060325A1 (enExample)
ZA (1) ZA200206553B (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6585963B1 (en) * 2001-02-15 2003-07-01 Watson Pharmaceuticals, Inc. Nail compositions and methods of administering same
GB0203276D0 (en) * 2002-02-12 2002-03-27 Novartis Ag Organic compounds
DE60318867T2 (de) 2002-09-05 2009-01-15 Galderma S.A. Lösung für die anwendung an nägeln
AU2004224326B2 (en) * 2003-03-21 2010-04-22 Nexmed Holdings, Inc. Antifungal nail coat and method of use
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US8741332B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
JP5010125B2 (ja) * 2005-09-02 2012-08-29 有限会社日本健康科学研究センター 水虫治療用フィルム製剤
WO2007056068A2 (en) * 2005-11-02 2007-05-18 Bentley Pharmaceuticals, Inc. Macrocyclic formulations for transmembrane drug delivery
EP1959929A4 (en) * 2005-12-14 2012-08-15 Zars Pharma Inc COMPOSITIONS AND METHODS FOR TREATING DERMATOLOGICAL SUFFERING
WO2007077806A1 (ja) * 2005-12-28 2007-07-12 Teikoku Seiyaku Co., Ltd. 爪用医薬組成物
WO2008091588A1 (en) 2007-01-22 2008-07-31 Targacept, Inc. Intranasal, buccal, and sublingual administration of metanicotine analogs
JP5654497B2 (ja) * 2009-02-13 2015-01-14 トピカ ファーマシューティカルズ，インコーポレイテッド 抗真菌製剤
PL2408299T3 (pl) * 2009-03-20 2014-03-31 Stiefel Laboratories Kompozycje monoglicerydu kwasu tłuszczowego
GB201021386D0 (en) * 2010-12-16 2011-01-26 Burke Michael H A process for the manufacture of an antifungal nail lacquer
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
EP3936133A1 (en) 2011-11-23 2022-01-12 TherapeuticsMD, Inc. Natural combination hormone replacement formulations and therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
AR100562A1 (es) 2014-05-22 2016-10-12 Therapeuticsmd Inc Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal
KR101580077B1 (ko) * 2015-03-28 2015-12-24 한국콜마주식회사 시크로피록스 함유 네일락카 조성물
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
RU2018133932A (ru) 2016-04-01 2020-05-12 Терапьютиксмд, Инк. Фармацевтическая композиция стероидного гормона
US10286077B2 (en) 2016-04-01 2019-05-14 Therapeuticsmd, Inc. Steroid hormone compositions in medium chain oils

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299826A (en) * 1979-10-12 1981-11-10 The Procter & Gamble Company Anti-acne composition
US5023252A (en) * 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
US5731303A (en) * 1985-12-04 1998-03-24 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery compositions
DE3720147A1 (de) * 1987-06-16 1988-12-29 Hoechst Ag Antimykotisch wirksamer nagellack sowie verfahren zu dessen herstellung
DE69216446T2 (de) * 1991-03-13 1997-06-26 Firmenich & Cie Verfahren zur Herstellung von 15-Pentadecanolid oder von an diesem Makrolid reichen Gemischen
CA2211004A1 (en) * 1994-10-20 1996-05-02 The Procter & Gamble Company Personal treatment compositions and/or cosmetic compositions containing enduring perfume
US5693828A (en) * 1996-05-09 1997-12-02 International Flavors & Fragrances Inc. Process for preparing lactones and intermediates therefor
CA2278328C (en) * 1998-02-09 2008-07-22 Macrochem Corporation Antifungal nail lacquer and method using same
US6231875B1 (en) * 1998-03-31 2001-05-15 Johnson & Johnson Consumer Companies, Inc. Acidified composition for topical treatment of nail and skin conditions
US6495124B1 (en) * 2000-02-14 2002-12-17 Macrochem Corporation Antifungal nail lacquer and method using same

Also Published As

Publication number Publication date
HUP0204555A3 (en) 2004-06-28
PL357111A1 (en) 2004-07-12
WO2001060325A1 (en) 2001-08-23
CA2400178A1 (en) 2001-08-23
TWI232756B (en) 2005-05-21
EP1257248A4 (en) 2007-10-03
EP1257248B1 (en) 2011-10-05
KR20030016227A (ko) 2003-02-26
KR20080049148A (ko) 2008-06-03
NO20023866D0 (no) 2002-08-15
AU2001243189B2 (en) 2005-06-09
NZ520749A (en) 2004-06-25
MA26883A1 (fr) 2004-12-20
CN1422142A (zh) 2003-06-04
EP1257248A1 (en) 2002-11-20
MXPA02008072A (es) 2004-04-05
NO20023866L (no) 2002-10-01
ZA200206553B (en) 2003-11-17
AU4318901A (en) 2001-08-27
JP2005503318A (ja) 2005-02-03
HUP0204555A2 (en) 2003-05-28
BR0108438A (pt) 2003-04-01

Similar Documents

Publication Publication Date Title
ATE526917T1 (de) Pharmazeutische zusammensetzung
EA200000964A1 (ru) Жидкие полимерные композиции для регулируемого выделения биоактивных веществ
EA200500084A1 (ru) Фармацевтическая композиция для чрескожной доставки активного агента
JP2005503318A5 (enExample)
MXPA03005375A (es) Formulacion repelente de insectos que contiene solventes polares, que tiene baja viscosidad y de entrega mediante dispositivo piezoelectrico.
DE69939180D1 (de) Pharmazeutische zubereitungen zur externen anwendung, die nicht steroidale antiinflammatorische und analgetische wirkstoffe enthalten
EA199900991A1 (ru) Медицинские аэрозольные препараты
PT1150661E (pt) Produto para pulverizacao para aplicacao topica
CA2548897A1 (en) Endoparasiticidal agents for topical application
ATE342048T1 (de) Neue aerosolformulierungen ein polares fluoriniertes molekül enthaltend
KR960700041A (ko) 신규한 경피 흡수제제(Novel percutaneously absorbable preparation)
MXPA04011990A (es) Composiciones farmaceuticas estabilizadas en la base de aceite de ricino polioxietilado y metodo para fabricar el mismo.
ATE242965T1 (de) Mittel zur viruziden händedesinfektion
DK1212039T3 (da) Sammensætning til inhalation omfattende delta-9-tetrahydrocannabinol i et semivandigt oplösningsmiddel
ES2111272T3 (es) Mezclas herbicidas.
BR112021023276A2 (pt) Cartucho compreendendo nicotina e um solvente imiscível em água
DE69828615D1 (de) Verwendung von inhibitoren der komplementaktivierung zur herstellung eines medikaments zur inhibierung von nebenwirkungen von pharmazeutischen zusammensetzungen, die amphiphile träger oder wirkstoffträger moleküle enthalten
DE60119914D1 (de) Verfahren zur herstellung von zusammensetzungen mit beschleunigter abgabe unter verwendung von komprimierten fluiden
DK1300143T3 (da) Plaster som indeholder 4-biphenyleddikesyre
CA2591307A1 (en) Injectable veterinary composition
JPH03505835A (ja) 経皮ドラッグデリバリーシステム
NO20055601L (no) Farmasoytisk preparat i form av en hydrogel for transdermal administrasjon av aktive virkestoffer
ATE214269T1 (de) Oral anzuwendende flüssige arzneilösung
ATE487492T1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
BR0112150A (pt) Veìculo para aplicação de compostos quìmicos em madeira

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties